We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+8.77%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.75%
AUM
$19.4B
AUM Growth
+$2.92B
(+18%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
9.31%
Top 10 Holdings %
Top 10 Hldgs %
20.62%
Holding
1,394
New
273
Increased
343
Reduced
316
Closed
453
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$694M |
| 2 |
Philip Morris
PM
|
+$316M |
| 3 |
Johnson & Johnson
JNJ
|
+$315M |
| 4 |
Merck
MRK
|
+$303M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$248M |
| 2 |
Micron Technology
MU
|
+$212M |
| 3 |
RAD
Rite Aid Corporation
RAD
|
+$196M |
| 4 |
Comcast
CMCSA
|
+$165M |
| 5 |
GSK
GSK
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.45% |
| 2 | Energy | 18.88% |
| 3 | Healthcare | 17.92% |
| 4 | Financials | 10.19% |
| 5 | Consumer Staples | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$4.72T
| $818M | 4.21% |
35,212,744
+32,592,056
| +1,244% | +$694M |
|
|
2
Philip Morris
PM
$298B
| $507M | 2.61% |
6,010,521
+3,665,945
| +156% | +$316M |
|
3
TSMC
TSM
$2.16T
| $448M | 2.3% |
20,925,460
+5,564,691
| +36% | +$115M |
|
4
Qualcomm
QCOM
$180B
| $396M | 2.04% |
5,001,852
+2,276,981
| +84% | +$181M |
|
|
5
Johnson & Johnson
JNJ
$624B
| $326M | 1.68% |
+3,117,484
| New | +$315M |
|
6
EOG Resources
EOG
$77.5B
| $323M | 1.66% |
2,759,960
+2,227,602
| +418% | +$234M |
|
|
SHPG
7
DELISTED
Shire pic
SHPG
| $309M | 1.59% |
1,311,415
-160,360
| -11% | -$27.9M |
|
|
8
Merck
MRK
$322B
| $307M | 1.58% |
+5,559,181
| New | +$303M |
|
9
Vodafone
VOD
$35.1B
| $289M | 1.49% |
8,650,307
+423,304
| +5% | +$15M |
|
10
Canadian Natural Resources
CNQ
$98B
| $288M | 1.48% |
12,950,769
+8,440,927
| +187% | +$169M |
|
11
AbbVie
ABBV
$454B
| $267M | 1.37% |
4,729,485
-391,497
| -8% | -$20.5M |
|
|
APC
12
DELISTED
Anadarko Petroleum
APC
| $255M | 1.31% |
2,326,005
+2,309,582
| +14,063% | +$235M |
|
|
LO
13
DELISTED
LORILLARD INC COM STK
LO
| $250M | 1.29% |
4,099,577
-142,818
| -3% | -$8.3M |
|
14
Kinder Morgan
KMI
$72.9B
| $247M | 1.27% |
6,801,875
+5,617,829
| +474% | +$190M |
|
15
Mastercard
MA
$469B
| $246M | 1.26% |
3,347,140
+558,369
| +20% | +$41.5M |
|
16
Nokia
NOK
$54.3B
| $240M | 1.23% |
31,755,947
+19,743,637
| +164% | +$150M |
|
17
AstraZeneca
AZN
$261B
| $236M | 1.21% |
3,174,970
-1,290,636
| -29% | -$93.3M |
|
18
iShares MSCI Taiwan ETF
EWT
$10.2B
| $214M | 1.1% |
6,768,179
+1,971,075
| +41% | +$59.1M |
|
19
Amgen
AMGN
$201B
| $213M | 1.1% |
1,802,764
+951,572
| +112% | +$110M |
|
|
20
GSK
GSK
$102B
| $212M | 1.09% |
3,174,296
-2,199,665
| -41% | -$149M |
|
21
ConocoPhillips
COP
$146B
| $208M | 1.07% |
+2,423,489
| New | +$189M |
|
|
DTV
22
DELISTED
DIRECTV COM STK (DE)
DTV
| $181M | 0.93% |
2,133,644
-1,042,353
| -33% | -$84.9M |
|
23
Intel
INTC
$504B
| $177M | 0.91% |
5,744,272
+1,418,874
| +33% | +$38.9M |
|
24
Tenaris
TS
$29B
| $175M | 0.9% |
3,713,295
+2,676,093
| +258% | +$120M |
|
25
Pfizer
PFE
$143B
| $174M | 0.89% |
6,174,355
+1,899,823
| +44% | +$54.2M |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2014 Portfolio in Review
As of Q2 2014, Arrowstreet Capital held 1,394 positions worth $19.4B, up 18% from $16.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Arrowstreet Capital deployed $1.81B of net new capital in Q2 2014, opening 273 new positions and adding to 343 existing holdings. Its largest new stake was Johnson & Johnson: 3,117,484 shares worth $326M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $248M trimmed.
- Arrowstreet Capital's largest Q2 2014 buy was Johnson & Johnson: 3,117,484 shares worth $326M.
- Arrowstreet Capital added most to Apple in Q2 2014, an estimated $694M increase.
- Arrowstreet Capital's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $248M.
- Arrowstreet Capital fully exited Comcast in Q2 2014, selling an estimated $165M.
- Arrowstreet Capital's ten largest holdings make up 21% of its $19.4B portfolio in Q2 2014.
- Arrowstreet Capital opened 273 new positions and closed 453 in Q2 2014.
- Arrowstreet Capital's portfolio value rose 18% quarter-over-quarter to $19.4B.
Based on Arrowstreet Capital's 13F filing for Q2 2014, filed 14 Aug 2014.